Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Immunogenic Potential of Biogenic Vs. Synthetic Selenium Nanoparticles in Vaccine Candidate Against Methicillin-Resistant Staphylococcus Aureus Publisher



Ranjbariyan A1 ; Haghighat S1 ; Yazdi MH2, 3 ; Bidgoli SA4 ; Tabriz HM5 ; Mahdavi M6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Microbiology, TeMS.C., Islamic Azad University, Tehran, Iran
  2. 2. Biotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Recombinant Vaccine Research Center, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Toxicology and Pharmacology, TeMS.C, Islamic Azad University, Tehran, Iran
  5. 5. Department of Pathology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Advanced Therapy Medicinal Product (ATMP) Department, Breast Cancer Research Center, Motamed Cancer Institute, Academic Center for Education, Culture, and Research (ACECR), Tehran, Iran

Source: Vaccine: X Published:2025


Abstract

MRSA-related antimicrobial-resistant infections are a significant public health issue. Vaccination can prevent infection by inducing pathogen immunity. The surface-associated protein autolysin is a promising vaccination candidate. This study investigated the immunogenicity and MRSA protection of a recombinant R-autolysin vaccination with SeNPs and aluminum adjuvants. R-autolysin was expressed and purified using nickel-nitrilotriacetic acid affinity chromatography. Synthetic and biogenic SeNPs are prepared from selenium dioxide and Lactiplantibacillus plantarum. Dynamic light scattering and scanning electron microscopy assessed SeNP shape and size. Balb/c mice received three subcutaneous vaccination injections with aluminum adjuvants and SeNPs over two weeks. ELISA measured cytokines and antibodies to determine the immunological response. Opsonophagocytosis tests, internal organ bacterial load, and experimental group survival rates assessed the vaccine's efficacy. Additionally, pathobiological changes were compared among the groups to determine any differences in response. The study demonstrated that mice immunized with SeNPs and r-autolysin produced more IgG, IgG1, and IgG2a antibodies and cytokines, including IFN-γ, TNF, IL-12, and IL-4, than the control group. The immunized mice had higher survival rates and lower internal organ bacterial burdens than the control group. The results indicate that SeNPs and r-autolysin improved the immune response and protected against MRSA infection. Biogenically and synthetically generated SeNPs improve immune response and reduce mouse mortality. Notably, synthetic SeNPs stimulated humoral immunity more than biogenic SeNPs, which stimulated cellular immunity. © 2025 The Authors
Experts (# of related papers)
Other Related Docs